Pegaspargase-based concurrent chemoradiotherapy in the treatment of stage I/II extranodal NK/T cell lymphoma: a single center, single arm, phase 2 clinical trial.

Trial Profile

Pegaspargase-based concurrent chemoradiotherapy in the treatment of stage I/II extranodal NK/T cell lymphoma: a single center, single arm, phase 2 clinical trial.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Pegaspargase (Primary)
  • Indications T cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top